the protective effect of antiarrhythmic agents for patients with malignant ventricular arrhythmia ( defined as noninfarction ventricular fibrillation or sustained hemodynamically compromising ventricular tachycardia ) remains uncertain .
C0085612
ventricular arrhythmia
C0042510
ventricular fibrillation